Approval · Notice of Compliance 35702 · 2025
PROPOFOL INJECTION: Notice of Compliance 35702
Issued July 22, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35702
- Date
- July 22, 2025
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DIPRIVAN (Aspen Pharmacare Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02559692 | Approved |
Medicinal ingredients
- PROPOFOL 10 MG per ML